Skip to main content

Table 1 Inclusion criteria

From: Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients

Age: ≥18years
WHO performance status: ≤ 2
Histologically-proven of primary cancer disease
M1 stage with primary cancer site radically treated with complete response/resection or stable.
No other site of disease in progression (a maximum of 3 lymph node sites of disease to treat)
Diameter: <5 cm
Abdomen/pelvic site  
No previous surgery or RT in the region to treat  
Informed consent.